Cocrystal Pharma Inc — Quarterly Financial Statistics (NASDAQ:COCP) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -21.53 M3.17 M-2.94 M-2.15 M-1.36 M -3.28 M Cash from investing activities 000012 K 12 K Cash from financing activities 00——0 — Free cash flow -21.53 M3.17 M-2.94 M-2.15 M-1.37 M -3.29 M

Haberler

Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial

Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB

Phillip Frost achète des actions de Cocrystal Pharma (COCP) pour 18.812€

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812

Cocrystal Pharma raises $1.03 million in private placement from directors

Cocrystal Pharma receives $500,000 NIH grant for influenza drug

Cocrystal Pharma clôture un placement direct enregistré de 4,7 millions $

Cocrystal Pharma closes $4.7 million registered direct offering

Cocrystal Pharma lève 4,7 millions de dollars par placement direct enregistré

Cocrystal Pharma raises $4.7 million in registered direct offering

Le médicament contre le norovirus CDI-988 de Cocrystal passe à l’étude de phase 1b

Cocrystal’s norovirus drug CDI-988 advances to phase 1b study